세계의 동물 바이오테크놀러지 시장 리포트(2023년)

“Animal Biotechnology Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal biotechnology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The animal biotechnology market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product Type: Diagnostics Tests; Vaccines; Drugs; Reproductive And Genetic; Feed Additives

• 2) By Animal Type: Companion; Livestock

• 3) By Application: Diagnosis Of Animal Diseases; Treatment Of Animal Diseases; Preventive Care Of Animals; Drug Development; Other Applications

• 4) By End-Use: Laboratories; Point-Of-Care Testing/In-house Testing; Veterinary Hospitals And Clinics; Other End-Uses

• Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Biogenesis Bago SA; Merck & Co Inc.; Virbac

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the animal biotechnology market are: Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Heska Corporation, Bayer AG, Pfizer Inc., Sanofi S A, Santa Cruz Biotechnology Inc., Indian Immunologicals Limited, Hester Biosciences Limited, Intervet Inc., Idvet, Abbott Laboratories, Genus PLC., Ivaoes Animal Health, and Novartis AG.

The global animal biotechnology market is expected to grow from $25.53 billion in 2022 to $27.67 billion in 2023 at a compound annual growth rate (CAGR) of 8.40%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The animal biotechnology market is expected to reach $38.32 billion in 2027 at a CAGR of 8.48%.

The animal biotechnology market includes revenues earned by entities by using animal biotechnology for dogs, cats, horses, poultry, swine, cattle, sheep, goats and fish. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Animal biotechnology refers to the use of science and engineering techniques by which living organisms are modified to benefit humans and other animals. The animal biotechnology is used to modify the genome of animals, known as genetic engineering, to improve their suitability in pharmaceuticals, industrial, and agriculture applications.

North America was the largest region in the animal biotechnology market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main type of product of animal biotechnology include diagnostics tests, vaccines, drugs, reproductive and genetic and feed additives that are animals such as companion and livestock. Diagnostics tests refer to a set of techniques that are used to diagnose a disease or condition of organisms. Animal biotechnology is applied in diagnosis of animal diseases, treatment of animal diseases, preventive care of animals, drug development and other applications and used in laboratories, point-of-care testing/in-house testing, veterinary hospitals & clinics and other end-use.

The growing awareness regarding animal health and welfare is expected to propel the animal biotechnology market going forward. Animal health and welfare are concerned with how people interact with animals and their responsibility to ensure that the animals in their care are handled appropriately and compassionately. In animal health and welfare, animal biotechnology helps in improving animal productivity via increasing growth, reproduction quality, nutrition, feed utilization, food safety, and others for more efficient utilization of resources. For instance, according to American Pet Products Association (APPA), a US-based trade association in the pet industry, approximately $123.6 billion was spent on pet products by United States citizens in 2021 and products include supplies, OTC Medicine, veterinary care, and others. Additionally, in July 2021, the Department of Animal Husbandry and Dairying, the India-based official department for livestock, allocated a budget of INR 54,618 crores ($106.83 million) for the development of animal husbandry and dairying across the country for the next 5 years. The schemes include livestock health and disease control, the national program for dairy development, national livestock mission, and others. Therefore, the growing awareness regarding animal health and welfare is driving the growth of the animal biotechnology market.

Product innovation is a key trend in the animal biotechnology market. Major market players are focussing their efforts on developing novel goods like virus-like particle (VLP) technology for vaccine development. For instance, in April 2022, Cadila Pharmaceuticals, an India-based multinational pharmaceutical company, introduced a three-dose rabies vaccine prepared using virus-like particle technology for rabies known as ThRabis®. Virus-like particles (VLPs) refer to a vaccine-developing technique that uses multiprotein structures to mimic the form and size of a virus particle but lacks the viral genome that potentially yields safer and cheaper vaccine candidates. ThRabis® consists of recombinant nanoparticle-based rabies G protein that generates antibodies against rabies G protein that neutralize the virus and impedes virus attachment to the cell to achieve protection against rabies.

In January 2020, Heska Corporation, a US-based company operating in veterinary and animal health diagnostic products acquired Scil animal care company GmbH for $125 million. Through this acquisition, Heska corporation aims to strengthen its product portfolio in animal biotechnology and its position in veterinary point of care laboratory and imaging diagnostics. Scil animal care company GmbH is an US-based company operating in animal biotechnology.

The countries covered in the Animal Biotechnology market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The animal biotechnology market research report is one of a series of new reports from The Business Research Company that provides animal biotechnology market statistics, including animal biotechnology industry global market size, regional shares, competitors with an Critical infrastructure protection market share, detailed animal biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the animal biotechnology industry. This animal biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Animal Biotechnology Market Characteristics

3. Animal Biotechnology Market Trends And Strategies

4. Animal Biotechnology Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Animal Biotechnology Market
• 4.2. Ukraine-Russia War Impact On Animal Biotechnology Market
• 4.3. Impact Of High Inflation On Animal Biotechnology Market

5. Animal Biotechnology Market Size And Growth

• 5.1. Global Animal Biotechnology Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Animal Biotechnology Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Animal Biotechnology Market Segmentation

• 6.1. Global Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Diagnostics Tests
• Vaccines
• Drugs
• Reproductive And Genetic
• Feed Additives
• 6.2. Global Animal Biotechnology Market, Segmentation By Animal Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Companion
• Livestock
• 6.3. Global Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Diagnosis Of Animal Diseases
• Treatment Of Animal Diseases
• Preventive Care Of Animals
• Drug Development
• Other Applications
• 6.4. Global Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Laboratories
• Point-Of-Care Testing/In-house Testing
• Veterinary Hospitals And Clinics
• Other End-Uses

7. Animal Biotechnology Market Regional And Country Analysis

• 7.1. Global Animal Biotechnology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Animal Biotechnology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Animal Biotechnology Market

• 8.1. Asia-Pacific Animal Biotechnology Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Animal Biotechnology Market

• 9.1. China Animal Biotechnology Market Overview
• 9.2. China Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Animal Biotechnology Market

• 10.1. India Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Animal Biotechnology Market

• 11.1. Japan Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Animal Biotechnology Market

• 12.1. Australia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Animal Biotechnology Market

• 13.1. Indonesia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Animal Biotechnology Market

• 14.1. South Korea Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Animal Biotechnology Market

• 15.1. Western Europe Animal Biotechnology Market Overview
• 15.2. Western Europe Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Animal Biotechnology Market

• 16.1. UK Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Animal Biotechnology Market

• 17.1. Germany Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Animal Biotechnology Market

• 18.1. France Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Animal Biotechnology Market

• 19.1. Eastern Europe Animal Biotechnology Market Overview
• 19.2. Eastern Europe Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Animal Biotechnology Market

• 20.1. Russia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Animal Biotechnology Market

• 21.1. North America Animal Biotechnology Market Overview
• 21.2. North America Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Animal Biotechnology Market

• 22.1. USA Animal Biotechnology Market Overview
• 22.2. USA Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Animal Biotechnology Market

• 23.1. South America Animal Biotechnology Market Overview
• 23.2. South America Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Animal Biotechnology Market

• 24.1. Brazil Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Animal Biotechnology Market

• 25.1. Middle East Animal Biotechnology Market Overview
• 25.2. Middle East Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Animal Biotechnology Market

• 26.1. Africa Animal Biotechnology Market Overview
• 26.2. Africa Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Animal Biotechnology Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Animal Biotechnology Market Competitive Landscape And Company Profiles

• 27.1. Animal Biotechnology Market Competitive Landscape
• 27.2. Animal Biotechnology Market Company Profiles
  • 27.2.1. Zoetis Inc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Boehringer Ingelheim International GmbH
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Biogenesis Bago SA
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Merck & Co Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Virbac
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Animal Biotechnology Market

29. Animal Biotechnology Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer